How to buy Genenta Science SpA stock in Canada

Own Genenta Science SpA shares in just a few minutes.

Genenta Science SpA is a biotechnology business based in the US. Genenta Science SpA shares (GNTA) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $3.83 – an increase of 8.81% over the previous week. Genenta Science SpA employs 14 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Genenta Science SpA ADR stock

Best for Beginners

Go to site
Easy to use app
  • $200 or more cash back offer
  • Get 100 free trades
  • Best platform for beginners

Best Overall

Go to site
Low margin rates
  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Best for Low Fees

Go to site
CA & US trading
  • 6% cash rebate plus $2,200 in trading perks
  • Low transaction fees
  • Easy-to-use app

How to buy Genenta Science SpA stock

  1. Choose a stock trading platform. Compare investment platforms.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – GNTA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Genenta Science SpA stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Product CAFST Finder Score Available Asset Types Account Types Stock Trading Fee Account Fee Offer
Interactive Brokers logo
Finder Score
Stocks, Bonds, Options, Index Funds, ETFs, Currencies, Futures
RRSP, TFSA, Personal, Joint
min $1.00, max 0.5%
$0
CIBC logo
Finder Score
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint
$6.95
$0 if conditions met, or $100
Get 100 free trades when you open a CIBC Investor’s Edge account using promo code EDGE2425. Plus, get $200 or more cash back. Valid until March 31, 2025.
Moomoo logo
Finder Score
Stocks, Options, ETFs
RRSP, TFSA, Personal
$0.014/stock
$0
Enjoy a 6% cash rebate, plus $2,200 in trading perks.
RBC Direct Investing logo
Finder Score
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint, Business
$6.95 - $9.95
$0 if conditions met, otherwise $25/quarter
Get a $300 cash bonus and up to 500,000 Avion points when you open your first eligible RBC Direct Investing account. Plus, get 50 commission-free trades to use within one year of account opening. Conditions apply. Offer ends March 3, 2025
Questrade logo
Finder Score
Stocks, Bonds, Options, Mutual Funds, ETFs, Forex, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal
$4.95 - $9.95
$0
Qtrade logo
Finder Score
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
RRSP, RESP, RRIF, TFSA, Personal, Joint
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get 1% cashback or more, a $150 sign-up bonus & unlimited free trades until April 30th, 2025.
loading

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Genenta Science SpA stock price (NASDAQ: GNTA)

Use our graph to track the performance of GNTA stocks over time.

Genenta Science SpA stocks at a glance

Information last updated 2025-02-07.
Latest market close$3.83
52-week range$2.20 - $7.28
50-day moving average $4.65
200-day moving average $4.19
Wall St. target price$21.60
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.51

Is it a good time to buy Genenta Science SpA stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genenta Science SpA price performance over time

Historical closes compared with the close of $3.94 from 2025-02-06

1 week (2025-01-31) 11.93%
1 month (2025-01-08) -22.59%
3 months (2024-11-08) -19.59%
6 months (2024-08-08) -14.35%
1 year (2024-02-08) 21.23%
2 years (2023-02-07) -37.26%
3 years (2022-02-07) 8.8661
5 years (2020-02-04) N/A

Genenta Science SpA financials

Gross profit TTM $0
Return on assets TTM -25.83%
Return on equity TTM -42.89%
Profit margin 0%
Book value $0.92
Market Capitalization $72.1 million

TTM: trailing 12 months

Genenta Science SpA stock dividends

We're not expecting Genenta Science SpA to pay a dividend over the next 12 months.

Genenta Science SpA stock price volatility

Over the last 12 months, Genenta Science SpA's stocks have ranged in value from as little as $2.2 up to $7.28. A popular way to gauge a stock's volatility is its "beta."

GNTA.US volatility(beta: 0.74)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genenta Science SpA's is 0.741. This would suggest that Genenta Science SpA's stocks are less volatile than average (for this exchange).

Genenta Science SpA overview

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages.

Frequently asked questions

What percentage of Genenta Science SpA is owned by insiders or institutions?
Currently 38.683% of Genenta Science SpA stocks are held by insiders and 8.339% by institutions.
How many people work for Genenta Science SpA?
Latest data suggests 14 work at Genenta Science SpA.
When does the fiscal year end for Genenta Science SpA?
Genenta Science SpA's fiscal year ends in December.
Where is Genenta Science SpA based?
Genenta Science SpA's address is: Via Olgettina No. 58, Milan, MI, Italy, 20132
What is Genenta Science SpA's ISIN number?
Genenta Science SpA's international securities identification number is: US36870W1009
What is Genenta Science SpA's CUSIP number?
Genenta Science SpA's Committee on Uniform Securities Identification Procedures number is: 36870W100
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

Ask a question

You must be logged in to post a comment.

More guides on Finder

Go to site